Immune dysregulation in SSc involves the activation and recruitment of several immune cells associated with the production of autoantibodies and cytokines, such as interleukin (IL)-1, IL-4, IL-6 and IL-13, and transforming growth factor (TGF)-β. The gene discussed is TGFB1; the disease is systemic sclerosis.